Innokas and Vitalth­ings: Syn­er­gis­tic col­lab­o­ra­tion in class IIb con­tact­less health mon­i­tor devel­op­ment

Devel­op­ing com­plex med­ical devices requires adapt­abil­i­ty, exper­tise, a deep under­stand­ing of reg­u­la­to­ry require­ments, and col­lab­o­ra­tion. That’s exact­ly what Innokas brought when part­ner­ing with Vitalth­ings, a Nor­we­gian HealthTech com­pa­ny spe­cial­iz­ing in con­tact­less health mon­i­tor­ing. Togeth­er, they devel­oped Guardian M10, an inno­v­a­tive res­pi­ra­to­ry mon­i­tor­ing device for hos­pi­tals and health­care insti­tu­tions, now offi­cial­ly MDR-cer­ti­fied as a Class IIb med­ical device.

Vitalth­ings select­ed Innokas as a devel­op­ment part­ner to help nav­i­gate the tech­no­log­i­cal, reg­u­la­to­ry, and time-to-mar­ket chal­lenges of bring­ing Guardian M10 to life. The col­lab­o­ra­tion began in ear­ly 2021 with an ini­tial pre-study phase, where Innokas sup­port­ed con­cept devel­op­ment, reg­u­la­to­ry plan­ning, and tech­ni­cal fea­si­bil­i­ty assess­ments. As the project evolved, Innokas expand­ed its involve­ment, guid­ing the prod­uct spec­i­fi­ca­tion, pro­duc­ti­za­tion, and even­tu­al tran­si­tion to man­u­fac­tur­ing. Close coor­di­na­tion between Innokas and Vitalth­ings was essen­tial in over­com­ing chal­lenges and keep­ing devel­op­ment aligned with mar­ket needs.

The suc­cess­ful part­ner­ship result­ed in a ful­ly cer­ti­fied, mar­ket-ready prod­uct. With Guardian M10 now in pro­duc­tion, Innokas and Vitalth­ings con­tin­ue their coop­er­a­tion on future inno­va­tions.

Read the full sto­ry here.

Source: Innokas Med­ical